BarcelonaMay 27 - 30ASCO 2026
ChicagoMay 29 - Jun 2EULAR 2026
ViennaJun 3 - 6EHA 2026
MilanJun 11 - 14BIO 2026San DiegoJun 16 - 19ENDO 2026BostonJun 18 - 21ADA 2026San FranciscoJun 19 - 22ESC 2026
LisbonAug 28 - Sep 1EASD 2026MadridSep 9 - 12ESMO 2026
BerlinSep 12 - 16ERS 2026
CopenhagenSep 12 - 15ECTRIMS 2026BarcelonaSep 17 - 20UEG Week 2026ViennaOct 3 - 7AHA 2026ChicagoNov 7 - 9ACR 2026Washington DCNov 14 - 19ASH 2026New OrleansDec 12 - 15ACC.27 Together With WCCHoustonApr 10 - 12EASL Congress 2026BarcelonaMay 27 - 30ASCO 2026ChicagoMay 29 - Jun 2EULAR 2026ViennaJun 3 - 6EHA 2026MilanJun 11 - 14BIO 2026San DiegoJun 16 - 19ENDO 2026BostonJun 18 - 21ADA 2026San FranciscoJun 19 - 22ESC 2026LisbonAug 28 - Sep 1EASD 2026MadridSep 9 - 12ESMO 2026BerlinSep 12 - 16ERS 2026CopenhagenSep 12 - 15ECTRIMS 2026BarcelonaSep 17 - 20UEG Week 2026ViennaOct 3 - 7AHA 2026ChicagoNov 7 - 9ACR 2026Washington DCNov 14 - 19ASH 2026New OrleansDec 12 - 15ACC.27 Together With WCCHoustonApr 10 - 12
The Life Science Feed
Podcast
Deep dives with clinicians, researchers, and industry leaders.
All episodesReplacing Biologic Injections With Oral Pills
Sarah Mitchell & James Carter
Psoriasis Monitoring Landscape Guide
Sarah Mitchell & James Carter
Why Half Of Psoriasis Patients Quit
Sarah Mitchell & James Carter
Is It Safe To Switch Biosimilars?
Sarah Mitchell & James Carter
Ebola Pandemic Risk in 2026: A Low Probability Assessment
An Ebola pandemic in 2026 is considered unlikely due to established public health responses, vaccine availability, and improved surveillance.
CGRP Inhibitors for Migraine: CV Safety Data Limited in High-Risk Patients
CGRP-targeted therapies are effective for migraine prevention, but cardiovascular safety data is limited in patients with established vascular disease.
FDA Approves OTC Switch for Topical Adapalene 0.1% Gel
The FDA has approved the first over-the-counter retinoid, adapalene 0.1% gel, for acne treatment, expanding access to a previously prescription-only therapy.
Next-Gen Extracellular Vesicles: Biomarkers, Targets, Deliverables in Oncology
Extracellular vesicles (EVs) and particles (EPs) offer new avenues for cancer diagnosis, prognosis, and therapy. Their role as biomarkers and drug delivery systems is expanding.
COVID Not Primary Driver of Pediatric Type 1 Diabetes Rise
Evidence suggests the observed increase in pediatric type 1 diabetes predates the COVID-19 pandemic, indicating other factors are at play.
Eosinophilic Disorders: Best Practices for HES and EGPA at ATS 2026
Managing hypereosinophilic syndrome (HES) and eosinophilic granulomatosis with polyangiitis (EGPA) presents diagnostic and therapeutic challenges.
Surgery Linked to Slight Cognitive Decline in Older Adults
Older adults undergoing surgery may experience a small but measurable decline in cognitive function, warranting careful preoperative assessment.
Alternaria Allergy in Youth Signals Persistent Asthma Risk
Early sensitization to Alternaria alternata in children and adolescents is a significant predictor of asthma persistence into adulthood.
Stay ahead in
Life Science.
EASL Congress 2026: Key Trials to Watch in Liver Disease Management
Variceal Bleeding Management: EASL 2026 Skills Centre Focuses on Endoscopic and Pharmacological Strategies
Late-Onset Genetic Cholestasis: Underdiagnosis in Adults Examined
HDV Management: EASL 2026 Highlights PegIFN-α as Standard
A-TANGO Score Refines ACLF Diagnosis, Prognosis in Cirrhosis
MASH Diagnosis: Non-Invasive Markers Show Promise at EASL 2026
EASL 2026 Forum: Enhancing Patient-Clinician Communication
EASL 2026: Liver and Spleen Elastography for Fibrosis Assessment
EASL 2026: Alcohol Policy Action Needed for Liver Disease
EASL 2026: PSC Therapies Advance Beyond Symptom Management
EASL 2026: Non-invasive Diagnostics Advance Liver Disease Staging
MASH Advanced Fibrosis: Experts Detail Unique Challenges at EASL 2026
MASLD Diagnosis Faces Barriers Despite 2024 EASL Guidelines
EASL 2026 Consensus: AATD-Liver Disease Management Standardised
EASL Congress 2026: Key Trials to Watch in Liver Disease Management
Variceal Bleeding Management: EASL 2026 Skills Centre Focuses on Endoscopic and Pharmacological Strategies
Late-Onset Genetic Cholestasis: Underdiagnosis in Adults Examined
HDV Management: EASL 2026 Highlights PegIFN-α as Standard
A-TANGO Score Refines ACLF Diagnosis, Prognosis in Cirrhosis
MASH Diagnosis: Non-Invasive Markers Show Promise at EASL 2026
EASL 2026 Forum: Enhancing Patient-Clinician Communication
EASL 2026: Liver and Spleen Elastography for Fibrosis Assessment
EASL 2026: Alcohol Policy Action Needed for Liver Disease
EASL 2026: PSC Therapies Advance Beyond Symptom Management
EASL 2026: Non-invasive Diagnostics Advance Liver Disease Staging
MASH Advanced Fibrosis: Experts Detail Unique Challenges at EASL 2026
MASLD Diagnosis Faces Barriers Despite 2024 EASL Guidelines
EASL 2026 Consensus: AATD-Liver Disease Management Standardised
Yoga Reduces Insomnia, Fatigue, Anxiety in Cancer Survivors
A new study presented at ASCO 2026 demonstrates yoga significantly improves insomnia, fatigue, and anxiety in cancer survivors.
ASCO 2026: Anticipating Advances in Oncology Treatment
ASCO 2026 is expected to highlight progress in targeted therapies, immunotherapy, and precision oncology, with a focus on biomarker-driven treatment strategies.
AI Integration Improves Lung Cancer MDT Workflow at ATS 2026
Integrating AI for lung cancer prediction into multidisciplinary team workflows demonstrates operational improvements and potential for enhanced patient stratification.
ATS 2026: Lung Cancer Management Advances in Targeted Therapy
6 min readMAVEs Inform Variant Interpretation in Clinical Oncology Practice
7 min readAI in Oncology: Practical Applications Transforming Cancer Care
7 min readDNA Methylation Patterns Emerge as Sarcoma Biomarkers
4 min readHTAN Decodes Tumor Evolution: Ecological Perspective at AACR2026
7 min readNext-Gen Extracellular Vesicles: Biomarkers, Targets, Deliverables in Oncology
7 min read
EASL Congress 2026: Key Trials to Watch in Liver Disease Management
EASL Congress 2026 will feature pivotal trials in NAFLD/NASH, HBV, and HCC, potentially reshaping current treatment paradigms.
Variceal Bleeding Management: EASL 2026 Skills Centre Focuses on Endoscopic and Pharmacological Strategies
EASL 2026 Skills Learning Centre will address variceal bleeding, highlighting current evidence for endoscopic and pharmacological interventions.
EASL 2026: Liver and Spleen Elastography for Fibrosis Assessment
EASL 2026 will feature a Skills Learning Centre on liver and spleen elastography, highlighting its role in non-invasive fibrosis assessment.
EASL 2026 Forum: Enhancing Patient-Clinician Communication
6 min readEASL 2026: Alcohol Policy Action Needed for Liver Disease
6 min readA-TANGO Score Refines ACLF Diagnosis, Prognosis in Cirrhosis
6 min readMASLD Diagnosis Faces Barriers Despite 2024 EASL Guidelines
5 min readEASL 2026: Non-invasive Diagnostics Advance Liver Disease Staging
7 min readLate-Onset Genetic Cholestasis: Underdiagnosis in Adults Examined
6 min read
Tricuspid Valve Surgery Benefits Adults with Systemic Right Ventricle
Adults with transposition of the great arteries (TGA) and systemic morphologic right ventricle (SRV) often develop SRV failure and tricuspid regurgitation (TR). A new study investigates the impact of tricuspid valve surgery (TVS) on clinical outcomes in this population.
Dual Plane Block May Cut Opioid Use After Bypass Surgery
A dual plane block technique for coronary artery bypass grafting (CABG) may reduce postoperative opioid consumption.
PAHO's HEARTS 2.0 Outlines 38-Step Pathway for Cardio-Renal Care
The PAHO HEARTS 2.0 initiative provides a 38-step pathway for integrated cardio-renal care, addressing the complex interplay of cardiovascular and kidney diseases.
Right Heart Catheterization: ATS 2026 Clarifies Waveform Interpretation
7 min readPrimary LV Unloading in Anterior STEMI Shows No Benefit in STEMI-Door to Unload Trial
6 min readDISCOVER INOCA Defines Vasomotor Disorders in Nonobstructive CAD
6 min readSex Differences in MINOCA Causes Identified by OCT and CMR Imaging
7 min readORBITA-CTO: CTO PCI Offers No Angina Relief Over Placebo
6 min readFFR or 3D-QCA Guided Revascularisation: The FAST III Trial
5 min read
The GLP-1 Muscle Loss Dilemma
The Velvet Rope Of Weight Loss Drugs
GLP-1 Drugs Protect Hearts And Kidneys
Rewiring The Brain To Silence Food Noise
1 min readCOVID Not Primary Driver of Pediatric Type 1 Diabetes Rise
6 min readTirzepatide: Efficacy in Weight Management Explored at ATS 2026
6 min readLower-Dose Tirzepatide: Can It Sustain Weight Loss Long-Term?
7 min readOral Orforglipron Sustains Weight Loss After Injectable GLP-1 Therapy
6 min readGLP-1 Drugs and Oral Medication Absorption: What Prescribers Need to Know
4 min readCGRP Inhibitors for Migraine: CV Safety Data Limited in High-Risk Patients
CGRP-targeted therapies are effective for migraine prevention, but cardiovascular safety data is limited in patients with established vascular disease.
Amyloid Therapies Show Limited Cognitive Benefit in AD
Current pharmacological therapies for Alzheimer's disease offer symptomatic relief but do not halt or reverse disease progression.
PARP1 Deficiency Reduces Amyloid Pathology in Familial AD Model
New preclinical work links PARP1 deficiency to reduced amyloid burden and cognitive preservation in a familial Alzheimer's model.
Brain Cooling After Thrombectomy: Does Hypothermia Aid LVO Recovery?
6 min readGut Microbiota Signal the Brain via the Vagus Nerve: What GPs Should Know
7 min readLow-Dose Lithium for Cognitive Decline: What the Evidence Actually Shows
7 min readParkinson's Neuroprotection 2025: Three Strategies Under Review
5 min read